These success, along with a earlier report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 aid the notion of targeting ACKR3 as a novel approach to modulate the opioid process, which could open up new therapeutic avenues for opioid-linked Conditions. Note: Benefits may change about https://yogiq616fwl1.blogitright.com/profile